Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-038658

Chief Executive Officer acquired 141,389 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Noiman Silvia · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-15 Grant or award : show line 1 in the form +141,389 141,389 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-06-15 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +141,389 141,389 D
2018-06-15 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…